Browse All

Current Filters

CLEAR FILTER x

TITLE

Overlapping and Distinguishing Features Among MS, NMOSD, MOGAD and Other Atypical Demyelinating Syndromes of the Central Nervous System

Author:Gulec, Bade   Cam, Abdulsamet   Bilge, Ugur   Tutuncu, Melih   Saip, Sabahattin   Uygunoglu, Ugur   Siva, Aksel   

Session Name:P11: MS Neuroimaging 2  

Topic:MS and Inflammatory Disease  

Program Number:P11.016  

Author Institution:Istanbul University Cerrahpasa-Cerrahpasa Medical Faculty, Istanbul, Turkey  Akdeniz University Faculty of Medicine, Antalya, Turkey  

African Americans with multiple sclerosis (MS) are more likely to have paramagnetic rim lesions (PRLs) compared to Caucasians

Author:Michaelson, Nara   Marcille, Melanie   Sweeney, Elizabeth   Kaunzner, Ulrike   Perumal, Jai   Nealon, Nancy   Nguyen, Thanh   Gauthier, Susan   

Session Name:P11: MS Neuroimaging 2  

Topic:MS and Inflammatory Disease  

Program Number:P11.017  

Author Institution:Weill Cornell Multiple Sclerosis, Department of Neurology, Weill Cornell Medicine, New York, NY  Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania , Philadelphia, PA  

Brain MRI Activity During the Year Before Pregnancy Can Predict Long-Term Clinical Worsening in Patients with Multiple Sclerosis

Author:Zveik, Omri   Kahila, Shahar   Levin, Netta   Rechtmen, Ariel   Haham, Nitzan   Vaknin-Dembinsky, Adi   

Session Name:P11: MS Neuroimaging 2  

Topic:MS and Inflammatory Disease  

Program Number:P11.018  

Author Institution:Hadassah-Hebrew University Medical Center, Tel Aviv, Israel  Hadassah-Hebrew University Medical Center, Jerusalem, Israel  

Impact of the COVID-19 Pandemic on Personal Networks and Neurological Outcomes of People with Multiple Sclerosis

Author:Venkatesh, Shruthi   Riley, Claire   Dhand, Amar   Doshi, Nandini   Kavak, Katelyn   Levit, Elle   Perrone, Christopher   Weinstock-Guttman, Bianca   Longbrake, Erin   De Jager, Philip   Xia, Zongqi   

Session Name:P12: MS COVID and Clinical Practice  

Topic:MS and Inflammatory Disease  

Program Number:P12.001  

Author Institution:University of Pittsburgh, Pittsburgh, PA  Columbia University Irving Medical Center, New York, NY  Brigham and Women's Hospital, Boston, MA  Jacobs MS Treatment and Research Center, Buffalo, NY  Yale University, Burlington, VT  University of Pennsylvania, Philadelphia, PA  Yale University, New Haven, CT  

COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD during the Omicron BA.1/2 wave in Singapore

Author:Tan, Kevin   Tye, Janis   Peng, Xuejuan   Wong, Daniel   Yeo, Tianrong   

Session Name:P12: MS COVID and Clinical Practice  

Topic:MS and Inflammatory Disease  

Program Number:P12.002  

Author Institution:National Neuroscience Institute, Singapore, Singapore